(Q43142299)
Statements
Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer (English)
Martin Pölcher
Meike Eckhardt
Christoph Coch
Matthias Wolfgarten
Walther Kuhn
Christian Rudlowski